Hydrazinocarbonyl-thieno(2,3-c)pyrazoles, preparation method, compositions containing same and use

Details for Australian Patent Application No. 2006219805 (hide)

Owner Aventis Pharma S.A.

Inventors Clerc, Francois-Frederic; Doerflinger, Gilles; Carry, Jean-Christophe; Barbalat-Damour, Dominique; Barberis, Claude; Minoux, Herve

Agent A J Park

Pub. Number AU-A-2006219805

PCT Pub. Number WO2006/092510

Priority 05 02199 04.03.05 FR

Filing date 3 March 2006

Wipo publication date 8 September 2006

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/4162 (2006.01) - condensed with heterocyclic ring systems

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

20 September 2007 PCT application entered the National Phase

  PCT publication WO2006/092510 Priority application(s): WO2006/092510

11 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006219823-Process for the production of fine chemicals

2006219802-1,2,4-triazine derivatives, preparation and use thereof in human therapy